Evidence map›Paper›PMID 41366654›Full record

ArticleBMC infectious diseases2025

Genomic characterization of non-O1, non-O139 Vibrio cholerae causing rare clinical manifestation.

Judit Henczkó, Márta Vargha, András Kállai, Katalin Kristóf, Ákos Tóth, Szilárd Tóth, Bernadett Pályi, Bernadett Khayer, Eszter Róka, Bereniké Novák and 4 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Judit HenczkóNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Márta VarghaDivision of Public Health Laboratory and Methodology, Department for Environmental Health Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
András KállaiDepartment of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.
Katalin KristófDepartment of Laboratory Medicine, Semmelweis University, Budapest, Hungary.
Ákos TóthDivision of Reference Laboratories for Microbiology, National Center for Public Health and Pharmacy, Budapest, Hungary.
Szilárd TóthDivision of Reference Laboratories for Microbiology, National Center for Public Health and Pharmacy, Budapest, Hungary.
Bernadett PályiNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Bernadett KhayerDivision of Public Health Laboratory and Methodology, Department for Environmental Health Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Eszter RókaDivision of Public Health Laboratory and Methodology, Department for Environmental Health Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Bereniké NovákNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Tünde MagDivision of Reference Laboratories for Microbiology, National Center for Public Health and Pharmacy, Budapest, Hungary.
Eszter MezeiCommunicable Diseases and Immunization Unit, National Center for Public Health and Pharmacy, Budapest, Hungary.
Zsuzsanna MolnárCommunicable Diseases and Immunization Unit, National Center for Public Health and Pharmacy, Budapest, Hungary.
Zoltán KisNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary. kis.zoltan@semmelweis.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-O1, non-O139 Vibrio cholerae is an uncommon cause of pneumonia, particularly following freshwater exposure. Non-O1, non-O139 Vibrio cholerae was identified from bronchoalveolar lavage through culture and quantitative polymerase chain reaction (qPCR) in Hungary. During an epidemiological investigation, the source of infection was traced to a designated bathing site at a lake in Central Hungary, where non-O1,non-O139 Vibrio cholerae was isolated from surface water.

methodsWe conducted whole-genome sequencing and comparative genomic analysis on a clinical isolate (N = 1) and three phenotypically distinct environmental isolates (N = 3). In addition, we reviewed the available literature on pulmonary infections associated with Vibrio cholerae.

resultsCore genome multilocus sequence typing (cgMLST) revealed that the clinical and environmental isolates clustered together with zero allelic differences. Multilocus sequence typing (MLST) identified a new sequence type (ST1605), representing a novel combination of known allele variants. In silico analysis of antibiotic resistance genes identified the presence of blaCARB-7. Both the clinical and environmental isolates exhibited identical virulence gene profiles, reinforcing the hypothesis that the infection was acquired from a local water source.

conclusionsThis study represents the first investigation of a primary pulmonary Vibrio cholerae infection reported in Europe following a near-drowning event. While Vibrio vulnificus and Vibrio metschnikovii have been implicated in similar pneumonia cases, the precise virulence mechanisms of these species remain poorly understood. Although non-O1, non-O139 Vibrio cholerae infections associated with recreational water exposure are rare in Hungary (1-2 cases per year), this study underscores the importance of ongoing surveillance for the detection of potential outbreaks and to inform public health responses.

Indexed as

Genome, BacterialVibrio choleraeVibrio cholerae non-O1Vibrio InfectionsFemaleGenomicsHumansHungaryMaleMultilocus Sequence TypingWhole Genome SequencingcgMLSTNon-O1Non-O139 Vibrio choleraePneumoniaWGS

Identifiers

PMID41366654
PMCPMC12801787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.